Systemic sclerosis (Scleroderma, SSc) is associated with major mortality and morbidity that arises from the development of specific complications of the disease, including organ-based complications. The frequency and diverse nature of these complications makes systematic assessment and long-term follow-up...
Systemic sclerosis is a chronic autoimmune disease characterized by three major features: widespread fibrosis in the skin and internal organs, a non-inflammatory small vessel oblite- rative vasculopathy and immunological activation with disease-specific autoantibodies. It is necessary to take a systematic...
Introduction: Interstitial lung disease (ILD) is the most common cause of mortality in systemic sclerosis; accounting for approximately 35% of deaths. Although immunosuppression is currently opted as first line therapy for scleroderma-related ILD (SSc-ILD), the benefits from it remain modest with ...
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res. 2012;64:519–524. doi:10.1002/acr.21583 (Open in a new window)PubMed (Open in a new window)Web of Science ®(Open in a new window)Google Scholar...
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Fibrosing alveolitis (FA) is a frequent and often fatal complication of systemic sclerosis (SSC). Alveolar inflammation has been recognized as a primary ev... JUERGEN BEHR,CLAUS VOGELMEIER,THOMAS BEINERT,... ...
3766 Oral Manifestations of Systemic Sclerosis and Consequences for Dental ManagementH. PETERS
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol. Ther. 19, 1116–1122 (2011). CAS PubMed PubMed Central Google Scholar Pramanik, D. et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits ...
Urinary tract infections (UTIs) are highly prevalent, lead to considerable patient morbidity, incur large financial costs to health-care systems and are one of the most common reasons for antibiotic use worldwide. The growing problem of antimicrobial resistance means that the search for nonantibiotic...
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis ...
Bergamasco, A., Hartmann, N., Wallace, L. & Verpillat, P. Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease.Clin. Epidemiol.11, 257–273 (2019). ArticleGoogle Scholar Johnson, J. et al. Differential diagnosis of asthma.Allergy Asthma...